Hepatitis Associated with Danazol

T. Ohsawa; Sanae Iwashita

doi:10.1177/106002808602001120

Hepatitis Associated with Danazol

T. Ohsawa, Sanae Iwashita

In: Drug Intelligence & Clinical Pharmacy · 1986 · vol. 20(11) , pp. 889 · doi:10.1177/106002808602001120 · PMID:3780430 · W2765257196

letter OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reports hepatitis as a potential adverse event associated with the use of the drug danazol.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

Liver Damage Induced by Danazol 1994

References (3)

[Increase in transaminases during treatment with danazol in lupus patients]. via openalex
Poor response to danazol in hemophilia via openalex
doi:10.1016/0091-6749(83)90034-9 via openalex

Cited by (1)

Liver Damage Induced by Danazol 1994

Source provenance

openalex: last seen: 2026-05-10T10:34:34.680553+00:00
unpaywall: last seen: 2026-06-02T02:00:03.124865+00:00

License: CC0 · commercial use OK

[1] Poor response to danazol in hemophilia 1985

[2] [Increase in transaminases during treatment with danazol in lupus patients]. 1985